Mesoblast Ltd (MESO) bonds
MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.91−0.54 (-4.34%)
Close on Nov 17, 2026Market cap $1.54BP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$129.83M
$21.19M due within a year
Net debt
$26.92M
After $102.91M of cash
Implied interest rate
15.59%
FY2026 interest ÷ average debt
Interest coverage
–
FY2026 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
Individual notes, bonds and loans
Mesoblast's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
See a number that looks wrong?